M&A

Fierce Pharma

AbbVie will continue to pursue external innovation for long-term

Amid reports that AbbVie is angling for a $1B buyout of neuroscience specialist Gilgamesh, the company revealed booming sales of Skyrizi and Rinvoq.

Kevin Dunleavy Jul 31, 2025 11:44am

graphic of a larger shark chomping up a smaller one

US and UK CROs merge to form global company

Jul 15, 2025 5:52pm

team layoffs workforce

GSK plans 'very limited' job cuts for global R&D team

Jul 15, 2025 4:15pm

A chessboard with blocks that read MA

Sino Biopharm buys Merck’s PD-1xVEGF bispecific partner LaNova

Jul 15, 2025 10:16am

Question

Fierce Pharma

Summit in high-stakes deal talks with AstraZeneca: Bloomberg

Jul 7, 2025 10:45am

The abstract concept of teamwork partnership merger alliance

Concentra strikes again, circling up IGM Biosciences

Jul 1, 2025 9:58am